Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Albireo Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 103 | 109 | +6 |
| Shares | 17.8M | 19.3M | +1.44M (+8.1%) |
| Value | $352.6M | $372.0M | +$19.5M (+5.5%) |
New holders (22)
Institutions that held Albireo Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Albireo Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Nicholas Investment Partners, LP | 430,878 | $8.56M |
| J. Goldman & Co LP | 231,278 | $4.59M |
| Sio Capital Management, LLC | 58,556 | $1.16M |
| Rafferty Asset Management, LLC | 57,758 | $1.15M |
| Qube Research & Technologies Ltd | 54,015 | $1.07M |
| UBS Oconnor LLC | 30,401 | $604.0K |
| Victory Capital Management Inc | 22,380 | $444.0K |
| Martingale Asset Management L P | 19,407 | $386.0K |
| CSS LLC | 12,143 | $241.0K |
| Gsa Capital Partners LLP | 10,079 | $200.0K |
| Caption Management, LLC | 4,300 | $85.0K |
| Steward Partners Investment Advisory, LLC | 900 | $18.0K |
| Curi Capital | 163 | $3.00K |
| Captrust Financial Advisors | 115 | $2.00K |
| Glassman Wealth Services | 9 | $0 |
| Parallel Advisors, LLC | 9 | $0 |